Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 8399

BillFederalHouseIn Committee
To amend the Internal Revenue Code of 1986 to deny the deduction for advertising and promotional expenses for prescription drugs.
About This Bill
Committee
Latest Action · September 25, 2020
Referred to the House Committee on Ways and Means.
Congress
116th (2019–2021)
Introduced
September 25, 2020
Sponsor
Rep. Abby FinkenauerD
Cosponsors (2)
2D 0R
View PDF ↗

Summary

Highlight any text to annotate
End Taxpayer Subsidies for Drug Ads Act This bill prohibits tax deductions for expenses relating to direct-to-consumer advertising of prescription drugs. Direct-to-consumer advertising is any dissemination, by or on behalf of a sponsor of a prescription drug product, of an advertisement that is (1) in regard to the drug product, and (2) primarily targeted to the general public.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.